Symbols / LIMN Stock $0.20 -0.75% Liminatus Pharma, Inc.

Healthcare • Biotechnology • United States • NGM
LIMN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Chris Kim J.D., L.L.M.
Exch · Country NGM · United States
Market Cap 8.89M
Enterprise Value 10.00M
Income -10.21M
Sales —
FCF (ttm) 7.14M
Book/sh -0.36
Cash/sh 0.01
Employees 1
Insider 10d —
IPO May 02, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S —
P/B -0.55
P/C —
EV/EBITDA -3.37
EV/Sales —
Quick Ratio 0.03
Current Ratio 0.05
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -0.43
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -62.65%
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 44.88M
Shs Float 29.07M
Insider Own 38.53%
Instit Own 0.71%
Short Float 6.12%
Short Ratio 0.28
Short Interest 1.99M
52W High 33.66
vs 52W High -99.41%
52W Low 0.16
vs 52W Low 24.65%
Beta 0.63
Impl. Vol. —
Rel Volume 0.06
Avg Volume 11.38M
Volume 633.94K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.20
Price $0.20
Change -0.75%
About

Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.20
Latest analyst target
3. DCF / Fair value
$2.86
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.20
Low
—
High
—
Mean
—
News
RSS: Latest LIMN news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
2.97
-10.88%
3.33
-30.90%
4.82
+77.89%
2.71
Research And Development
0.00
-100.00%
2.69
-28.52%
3.76
+102.75%
1.85
Selling General And Administration
2.97
+360.40%
0.64
-39.30%
1.06
+24.07%
0.86
General And Administrative Expense
2.97
+360.40%
0.64
-39.30%
1.06
+24.07%
0.86
Other Gand A
2.97
+360.40%
0.64
-39.30%
1.06
+24.07%
0.86
Total Expenses
2.97
-10.88%
3.33
-30.90%
4.82
+77.89%
2.71
Operating Income
-2.97
+10.88%
-3.33
+30.90%
-4.82
-77.89%
-2.71
Total Operating Income As Reported
-2.97
+10.88%
-3.33
+30.90%
-4.82
-77.89%
-2.71
EBITDA
-9.99
-211.43%
-3.21
+33.30%
-4.81
-77.52%
-2.71
Normalized EBITDA
-10.45
-225.66%
-3.21
+33.30%
-4.81
-77.52%
-2.71
Reconciled Depreciation
0.00
0.00
—
—
EBIT
-9.99
-211.48%
-3.21
+33.30%
-4.81
-77.52%
-2.71
Total Unusual Items
0.46
0.00
—
—
Total Unusual Items Excluding Goodwill
0.46
0.00
—
—
Special Income Charges
0.40
0.00
—
—
Other Special Charges
-0.40
—
—
—
Net Income
-10.21
-187.81%
-3.55
+28.85%
-4.98
-70.22%
-2.93
Pretax Income
-10.21
-187.81%
-3.55
+28.85%
-4.98
-70.22%
-2.93
Net Non Operating Interest Income Expense
-0.14
+35.61%
-0.22
-31.12%
-0.17
+24.66%
-0.22
Interest Expense Non Operating
0.22
-36.29%
0.34
+93.65%
0.17
-20.09%
0.22
Net Interest Income
-0.14
+35.61%
-0.22
-31.12%
-0.17
+24.66%
-0.22
Interest Expense
0.22
-36.29%
0.34
+93.65%
0.17
-20.09%
0.22
Interest Income Non Operating
0.08
-37.49%
0.12
+1125.26%
0.01
0.00
Interest Income
0.08
-37.49%
0.12
+1125.26%
0.01
0.00
Other Income Expense
-7.10
—
—
—
Other Non Operating Income Expenses
-7.56
—
—
—
Gain On Sale Of Security
0.05
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-10.21
-187.81%
-3.55
+28.85%
-4.98
-70.22%
-2.93
Net Income From Continuing Operation Net Minority Interest
-10.21
-187.81%
-3.55
+28.85%
-4.98
-70.22%
-2.93
Net Income From Continuing And Discontinued Operation
-10.21
-187.81%
-3.55
+28.85%
-4.98
-70.22%
-2.93
Net Income Continuous Operations
-10.21
-187.81%
-3.55
+28.85%
-4.98
-70.22%
-2.93
Normalized Income
-10.66
-200.68%
-3.55
+28.85%
-4.98
-70.22%
-2.93
Net Income Common Stockholders
-10.21
-187.81%
-3.55
+28.85%
-4.98
-70.22%
-2.93
Diluted EPS
—
-0.14
+28.85%
-0.19
-70.22%
-0.11
Basic EPS
—
-0.14
+28.85%
-0.19
-70.22%
-0.11
Basic Average Shares
—
26.01
+0.00%
26.01
+0.00%
26.01
Diluted Average Shares
—
26.01
+0.00%
26.01
+0.00%
26.01
Diluted NI Availto Com Stockholders
-10.21
-187.81%
-3.55
+28.85%
-4.98
-70.22%
-2.93
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
0.51
-90.52%
5.41
+141.25%
2.24
-67.24%
6.84
Current Assets
0.50
-90.52%
5.28
+135.68%
2.24
-67.25%
6.84
Cash Cash Equivalents And Short Term Investments
0.34
+499.54%
0.06
-87.02%
0.43
-91.40%
5.05
Cash And Cash Equivalents
0.34
+499.54%
0.06
-87.02%
0.43
-91.40%
5.05
Cash Financial
0.34
+499.54%
0.06
-87.02%
0.43
-91.40%
5.05
Receivables
0.00
-100.00%
3.67
+288.20%
0.94
+845.00%
0.10
Loans Receivable
0.00
-100.00%
3.67
+347.92%
0.82
0.00
Prepaid Assets
—
—
0.00
-100.00%
1.68
Current Deferred Assets
0.00
-100.00%
1.40
+66.82%
0.84
0.00
Other Current Assets
0.16
+4.77%
0.16
+606.82%
0.02
+120.00%
0.01
Total Non Current Assets
0.01
-90.39%
0.13
+12621.60%
0.00
+0.00%
0.00
Net PPE
0.01
+1198.72%
0.00
-5.90%
0.00
+0.00%
0.00
Non Current Accounts Receivable
—
0.13
—
—
Total Liabilities Net Minority Interest
10.33
-58.27%
24.75
+37.22%
18.04
+2.17%
17.65
Current Liabilities
10.30
-58.39%
24.75
+37.22%
18.04
+2.17%
17.65
Payables And Accrued Expenses
8.36
+74.96%
4.78
+140.48%
1.99
+72.25%
1.15
Payables
8.15
+135.55%
3.46
+152.61%
1.37
+92.42%
0.71
Accounts Payable
0.58
-60.75%
1.48
+58.98%
0.93
+83.66%
0.51
Other Payable
7.36
—
0.24
—
Current Accrued Expenses
0.20
-84.49%
1.32
+113.49%
0.62
+39.68%
0.44
Current Debt And Capital Lease Obligation
1.44
-92.78%
19.97
+24.44%
16.05
-2.73%
16.50
Current Debt
1.44
-92.78%
19.97
+24.44%
16.05
-2.73%
16.50
Other Current Borrowings
1.44
-92.78%
19.97
+24.44%
16.05
-2.73%
16.50
Current Deferred Liabilities
0.50
0.00
—
—
Total Non Current Liabilities Net Minority Interest
0.03
0.00
0.00
0.00
Stockholders Equity
-9.81
+49.25%
-19.34
0.00
0.00
Common Stock Equity
-9.81
+49.25%
-19.34
-22.45%
-15.79
-46.11%
-10.81
Capital Stock
0.00
+54.63%
0.00
—
—
Common Stock
0.00
+54.63%
0.00
—
—
Preferred Stock
0.00
0.00
—
—
Share Issued
27.06
+4.04%
26.01
+0.00%
26.01
+0.00%
26.01
Ordinary Shares Number
27.06
+4.04%
26.01
+0.00%
26.01
+0.00%
26.01
Additional Paid In Capital
29.05
+211.63%
9.32
—
—
Retained Earnings
-38.87
-35.61%
-28.67
-14.12%
-25.12
-24.75%
-20.14
Total Equity Gross Minority Interest
-9.81
+49.25%
-19.34
-22.45%
-15.79
-46.11%
-10.81
Total Capitalization
-9.81
+49.25%
-19.34
-22.45%
-15.79
-46.11%
-10.81
Working Capital
-9.80
+49.67%
-19.47
-23.25%
-15.79
-46.10%
-10.81
Invested Capital
-8.37
-1422.75%
0.63
+147.24%
0.26
-95.50%
5.69
Total Debt
1.44
-92.78%
19.97
+24.44%
16.05
-2.73%
16.50
Net Debt
1.10
-94.45%
19.92
+27.54%
15.62
+36.36%
11.45
Net Tangible Assets
-9.81
+49.25%
-19.34
0.00
0.00
Tangible Book Value
-9.81
+49.25%
-19.34
-22.45%
-15.79
-46.11%
-10.81
Derivative Product Liabilities
0.03
0.00
—
—
Duefrom Related Parties Current
—
—
0.13
+26.00%
0.10
Duefrom Related Parties Non Current
0.00
-100.00%
0.13
—
—
Dueto Related Parties Current
0.21
-89.40%
1.98
+352.53%
0.44
+114.22%
0.20
General Partnership Capital
—
—
4.61
-10.60%
5.16
Interest Payable
0.20
-78.65%
0.96
+55.05%
0.62
+39.68%
0.44
Limited Partnership Capital
—
—
4.71
+13.13%
4.17
Total Partnership Capital
—
—
-15.79
-46.11%
-10.81
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-9.96
-586.62%
-1.45
+56.62%
-3.35
-284.93%
-0.87
Cash Flow From Continuing Operating Activities
-9.96
-586.62%
-1.45
+56.62%
-3.35
-284.93%
-0.87
Net Income From Continuing Operations
-10.21
-187.81%
-3.55
+28.85%
-4.98
-70.22%
-2.93
Depreciation Amortization Depletion
0.00
0.00
—
—
Depreciation
0.00
0.00
—
—
Depreciation And Amortization
0.00
0.00
—
—
Other Non Cash Items
-0.08
—
—
0.90
Operating Gains Losses
7.31
—
—
—
Gain Loss On Investment Securities
-0.05
—
—
—
Gain Loss On Sale Of PPE
7.36
0.00
—
—
Change In Working Capital
-6.98
-433.34%
2.10
+27.84%
1.64
+41.42%
1.16
Change In Receivables
-3.43
0.00
—
—
Change In Prepaid Assets
—
—
1.68
+76.71%
0.95
Change In Payables And Accrued Expense
-3.88
-274.19%
2.23
+176.15%
0.81
+273.61%
0.22
Change In Accrued Expense
0.22
-69.11%
0.70
+299.36%
0.17
+60.55%
0.11
Change In Payable
-4.10
-367.90%
1.53
+142.03%
0.63
+490.65%
0.11
Change In Account Payable
-4.04
-37448.53%
-0.01
-102.53%
0.42
+377.53%
0.09
Change In Other Working Capital
—
—
-0.84
—
Change In Other Current Assets
0.32
+343.61%
-0.13
-1010.43%
-0.01
-20.00%
-0.01
Investing Cash Flow
-0.79
+72.35%
-2.85
-247.99%
-0.82
0.00
Cash Flow From Continuing Investing Activities
-0.79
+72.35%
-2.85
-247.99%
-0.82
0.00
Net PPE Purchase And Sale
-0.01
0.00
—
—
Purchase Of PPE
-0.01
0.00
—
—
Capital Expenditure
-0.01
—
—
—
Net Other Investing Changes
-0.78
+72.81%
-2.85
-247.99%
-0.82
—
Financing Cash Flow
11.03
+181.23%
3.92
+971.78%
-0.45
-107.61%
5.92
Cash Flow From Continuing Financing Activities
11.03
+181.23%
3.92
+971.78%
-0.45
-107.61%
5.92
Net Issuance Payments Of Debt
3.04
-22.51%
3.92
+971.78%
-0.45
-118.62%
2.42
Issuance Of Debt
4.34
+10.63%
3.92
+15.18%
3.41
-63.93%
9.44
Repayment Of Debt
-1.30
0.00
+100.00%
-3.86
+45.11%
-7.03
Short Term Debt Issuance
4.34
+10.63%
3.92
+15.18%
3.41
-63.93%
9.44
Short Term Debt Payments
-1.30
0.00
+100.00%
-3.86
+45.11%
-7.03
Net Short Term Debt Issuance
3.04
-22.51%
3.92
+971.78%
-0.45
-118.62%
2.42
Net Common Stock Issuance
10.56
0.00
0.00
-100.00%
3.50
Common Stock Payments
—
—
0.00
+100.00%
-0.70
Repurchase Of Capital Stock
—
—
0.00
+100.00%
-0.70
Net Other Financing Charges
-2.56
—
—
—
Changes In Cash
0.28
+174.41%
-0.38
+91.81%
-4.61
-191.40%
5.05
Beginning Cash Position
0.06
-87.03%
0.43
-91.39%
5.05
0.00
End Cash Position
0.34
+499.54%
0.06
-87.02%
0.43
-91.40%
5.05
Free Cash Flow
-9.98
-587.52%
-1.45
+56.62%
-3.35
-284.93%
-0.87
Interest Paid Supplemental Data
—
—
0.00
-100.00%
0.50
Income Tax Paid Supplemental Data
—
—
0.00
0.00
Change In Interest Payable
0.22
-36.29%
0.34
+93.65%
0.17
+60.55%
0.11
Common Stock Issuance
10.56
0.00
0.00
-100.00%
4.20
Issuance Of Capital Stock
10.56
0.00
0.00
-100.00%
4.20
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category